Doctor profile · Federal record
Dr. Paul Mazzeo, M.D.
Neurology Physician (CMS: Neurology) · Port Royal, SC
- NPI 1568432185
- Accepts Medicare
- MIPS 88.5 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1833 N. Paris Avenue
Port Royal, SC 299352029
(843) 522-1420
fax (843) 522-1460
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- October 13, 2010
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- South Carolina #17802
- Medicaid
- SC #178024
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568432185. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
90,023
Distinct HCPCS
10
Medicare allowed
$829,463
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0174 |
Injection, lecanemab-irmb, 1 mg | 52,500 | 15 | $1 | |
J0585 |
Injection, onabotulinumtoxina, 1 unit | 21,700 | 38 | $6 | |
J3032 |
Injection, eptinezumab-jjmr, 1 mg | 9,100 | 15 | $17 | |
J0586 |
Injection, abobotulinumtoxina, 5 units | 3,660 | 12 | $8 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 705 | 487 | $169 | |
99483 |
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 323 | 267 | $256 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 275 | 275 | $208 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 259 | 196 | $120 | |
95886 |
Needle measurement of electrical activity in arm or leg muscles, complete study | 173 | 161 | $90 | |
96372 |
Injection of drug or substance under skin or into muscle | 157 | 39 | $13 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 2,903. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$11,295
Transactions
116
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Eisai Inc. | 27 | $8,817.51 | |
| ABBVIE INC. | 14 | $371.75 | |
| Lundbeck LLC | 12 | $283.55 | |
| Teva Pharmaceuticals USA, Inc. | 8 | $214.44 | |
| EMD Serono, Inc. | 9 | $209.86 | |
| TG Therapeutics, Inc. | 8 | $189.26 | |
| Lilly USA, LLC | 9 | $168.87 | |
| Alexion Pharmaceuticals, Inc. | 6 | $152.12 | |
| Genentech USA, Inc. | 5 | $138.13 | |
| ACADIA Pharmaceuticals Inc | 4 | $120.17 | |
| Amgen Inc. | 5 | $95.44 | |
| ARGENX US, INC. | 3 | $84.36 | |
| Noctrix Health, Inc. | 1 | $82.40 | |
| PFIZER INC. | 3 | $59.05 | |
| SK Life Science, Inc. | 2 | $55.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,064
Patients
322
Total drug cost
$44,469
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Donepezil Hcl | Generic | 351 | 128 | $4,423 |
| Memantine Hcl | Generic | 220 | 75 | $10,583 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 56 | 23 | $1,894 |
| Levetiracetam | Generic | 52 | 12 | $2,011 |
| Gabapentin | Generic | 49 | 14 | $1,810 |
| Escitalopram Oxalate | Generic | 47 | 20 | $787 |
| Duloxetine Hcl | Generic | 41 | 13 | $2,242 |
| Topiramate | Generic | 41 | 0 | $542 |
| Quetiapine Fumarate | Generic | 33 | 11 | $985 |
| Rivastigmine | Generic | 31 | 0 | $8,801 |
Hospital affiliations
Frequently asked questions
What is Dr. Paul Mazzeo's medical specialty?
Dr. Paul Mazzeo practices Neurology Physician in Port Royal, SC.
Where does Dr. Paul Mazzeo practice?
Dr. Paul Mazzeo practices at 1833 N. Paris Avenue, Port Royal, SC 299352029. Office phone: 8435221420.
What is Dr. Paul Mazzeo's NPI?
Dr. Paul Mazzeo's National Provider Identifier (NPI) is 1568432185, issued by NPPES.
Does Dr. Paul Mazzeo accept Medicare assignment?
Yes. Dr. Paul Mazzeo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paul Mazzeo commonly perform?
Top Medicare-reported procedures in 2023: Injection, lecanemab-irmb, 1 mg (HCPCS J0174); Injection, onabotulinumtoxina, 1 unit (HCPCS J0585); Injection, eptinezumab-jjmr, 1 mg (HCPCS J3032). Source: CMS Medicare Physician & Other Practitioners file.